Sensex
73,852.90 profit arw -876.37 (-1.17%)
Nifty
22,888.95 profit arw -257.20 (-1.11%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 16-Oct-2026
Corporate News
16-Oct-2026     17:43


Mankind Pharma redeemed Rs 12.5 billion in NCDs and paid interest to debenture holders

Mankind Pharma Limited announced that it has paid interest and redemption amounts to holders of its Non-Convertible Debentures, INE634S07025 and INE634S07033, on October 16, 2026, as per Regulation 57(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company paid Rs 500,743,150 gross interest (Rs 499,741,677 net of taxes) on ISIN INE634S07025 and Rs 998,979,452 gross interest (Rs 998,579,873 net of taxes) on ISIN INE634S07033, and fully redeemed a total of 1,25,000 NCDs with a combined value of Rs 12,50,00,00,000.

INDIAN INDICES

Sensex

73,852.90 -876.37 (-1.17%)

Nifty

22,888.95 -257.20 (-1.11%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

23,878.21 -308.63(-1.28%)